Bronchial disorder
MONDO:0001358A disease involving the bronchus.
Also known as: bronchial disorder, bronchospasm, bronchus disease, bronchus disease or disorder, disease of bronchus, disease or disorder of bronchus, disorder of bronchus
1010 clinical trials for this condition and its sub-types, 19 tagged with Bronchial disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Bronchial disorder
-
Asthma 724 trials · 819 incl. sub-types
8 sub-types
- Chronic asthma 114 trials · 156 incl. sub-types Sub-types →
- Childhood onset asthma 111 trials
- Allergic asthma 41 trials Sub-types →
- Acute asthma 39 trials · 40 incl. sub-types Sub-types →
- Status asthmaticus 26 trials
- Intrinsic asthma 4 trials · 12 incl. sub-types Sub-types →
- Cough variant asthma 3 trials
- Occupational asthma 3 trials
-
Bronchiectasis 118 trials · 119 incl. sub-types
1 sub-type
- Idiopathic bronchiectasis 3 trials Sub-types →
-
Bronchitis 24 trials · 50 incl. sub-types
2 sub-types
- Chronic bronchitis 23 trials
- Croup 5 trials
-
Bronchial neoplasm 20 trials · 38 incl. sub-types
5 sub-types
- Bronchus cancer 3 trials · 26 incl. sub-types Sub-types →
- Bronchial endocrine tumor 4 trials
- Bronchus adenoma 0 trials Sub-types →
- Endobronchial leiomyoma 0 trials
- Endobronchial lipoma 0 trials
-
Non-syndromic bridging bronchus 0 trials
Most studied deeper sub-types
-
Video chats boost asthma med adherence in young patients
Disease control CompletedThis study tested whether video-based medication coaching helps adolescents and young adults with uncontrolled asthma take their inhaled steroids more regularly. 375 participants received either standard care or telehealth sessions to improve medication use. The goal was to see i…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug verekitug aims to curb severe asthma attacks
Disease control CompletedThis study tested a new drug called verekitug (UPB-101) in 479 adults with severe asthma. The goal was to see if it could reduce asthma attacks and improve lung function compared to a placebo. Participants received either verekitug or a dummy injection over several months. The tr…
Phase 2 • Sponsor: Upstream Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New asthma inhaler shows promise in early trial
Symptom relief CompletedThis study tested a single dose of a new albuterol inhaler called PT007 in 118 adults with asthma. Researchers compared how well it opened airways and its safety against a placebo inhaler and the standard Ventolin inhaler. The goal is to see if PT007 works as a quick-relief treat…
Phase 2 • Sponsor: AstraZeneca • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
Which spacer works best for wheezing tots? new study has answers
Symptom relief CompletedThis study tested two different spacer devices (valved holding chambers) used to give asthma medicine to children aged 6 months to 4 years with sudden wheezing. 80 children from Finnish hospitals took part. The goal was to see if one spacer worked better for symptom relief, hospi…
Sponsor: Tampere University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Inhaler training for kids could slash ER trips
Knowledge-focused CompletedThis study looked at whether teaching children (ages 2-15) with bronchospasm and their families how to properly use inhaler chambers can cut down on repeat emergency room visits. Half of the 121 participants received special education on inhaler use, while the other half got stan…
Sponsor: Puerta de Hierro University Hospital • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Researchers dive deep into mysterious lung disease
Knowledge-focused CompletedThis study looked at 275 adults with a lung condition called bronchiectasis, where airways are stretched and trap mucus, leading to infections. The goal was to learn more about the physical traits, lung scans, and germs in the lungs of people with the unexplained form of the dise…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC